Germanium Dioxide Nanoparticles Mitigate Biochemical and Molecular Changes Characterizing Alzheimer’s Disease in Rats

Alzheimer’s disease (AD) is a neurodegenerative disorder that jeopardizes the lives of diagnosed patients at late stages. This study aimed to assess, for the first time, the efficiency of germanium dioxide nanoparticles (GeO(2)NPs) in mitigating AD at the in vivo level compared to cerium dioxide nan...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdel Gaber, Sara A., Hamza, Amal H., Tantawy, Mohamed A., Toraih, Eman A., Ahmed, Hanaa H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220875/
https://www.ncbi.nlm.nih.gov/pubmed/37242628
http://dx.doi.org/10.3390/pharmaceutics15051386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220875/
https://www.ncbi.nlm.nih.gov/pubmed/37242628
http://dx.doi.org/10.3390/pharmaceutics15051386

Ejemplares similares